Clinical Trial Update: Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating low-dose naltrexone in children with pervasive developmental disorder, spanning Phase 1 and Phase 2, with the trial status listed as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pervasive Developmental Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Pervasive Developmental Disorder | Phase 1, Phase 2 | Status: UNKNOWN